CVS Health Corporation provided earnings guidance for the year 2023. For 2023, the company expects EPS at the upper end of previously indicated range of $8.50 to $8.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.7 USD | -1.43% | -6.48% | -28.19% |
06-27 | Walgreens cuts 2024 profit forecast, announces store closures | RE |
06-27 | Walgreens cuts 2024 profit forecast on worse-than-expected consumer spending | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.19% | 72.21B | |
+20.64% | 83.73B | |
-0.35% | 26.2B | |
+1.39% | 17.18B | |
-10.31% | 17.09B | |
+2.19% | 15.18B | |
+78.22% | 13.59B | |
+79.75% | 13.11B | |
-22.98% | 12.92B | |
+21.62% | 12.36B |
- Stock Market
- Equities
- CVS Stock
- News CVS Health Corporation
- CVS Health Corporation Provides Earnings Guidance for the Year 2023